BRPI0817524A2 - liberação prolongada de análogos de compstatina provenientes de géis - Google Patents
liberação prolongada de análogos de compstatina provenientes de géisInfo
- Publication number
- BRPI0817524A2 BRPI0817524A2 BRPI0817524A BRPI0817524A BRPI0817524A2 BR PI0817524 A2 BRPI0817524 A2 BR PI0817524A2 BR PI0817524 A BRPI0817524 A BR PI0817524A BR PI0817524 A BRPI0817524 A BR PI0817524A BR PI0817524 A2 BRPI0817524 A2 BR PI0817524A2
- Authority
- BR
- Brazil
- Prior art keywords
- gels
- prolonged release
- compstatin analogues
- compstatin
- analogues
- Prior art date
Links
- RDTRHBCZFDCUPW-KWICJJCGSA-N 2-[(4r,7s,10s,13s,19s,22s,25s,28s,31s,34r)-4-[[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]-34-[[(2s,3s)-2-amino-3-methylpentanoyl]amino]-25-(3-amino-3-oxopropyl)-7-[3-(diaminomethylideneamino)propyl]-10,13-bis(1h-imidazol-5-ylmethyl)-19-(1h-indol Chemical class C([C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CSSC[C@@H](C(N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)NCC(=O)N[C@@H](CC=2NC=NC=2)C(=O)N1)C(C)C)C(C)C)=O)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=CN=CN1 RDTRHBCZFDCUPW-KWICJJCGSA-N 0.000 title 1
- 239000000499 gel Substances 0.000 title 1
- 230000002035 prolonged effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nanotechnology (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97691907P | 2007-10-02 | 2007-10-02 | |
| US2646008P | 2008-02-05 | 2008-02-05 | |
| PCT/US2008/078593 WO2009046198A2 (en) | 2007-10-02 | 2008-10-02 | Sustained delivery of compstatin analogs from gels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0817524A2 true BRPI0817524A2 (pt) | 2017-05-02 |
Family
ID=40526950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0817524A BRPI0817524A2 (pt) | 2007-10-02 | 2008-10-02 | liberação prolongada de análogos de compstatina provenientes de géis |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110182877A1 (enExample) |
| EP (1) | EP2207530A4 (enExample) |
| JP (1) | JP2010540654A (enExample) |
| KR (2) | KR20100094453A (enExample) |
| CN (1) | CN101854916A (enExample) |
| AU (1) | AU2008308657A1 (enExample) |
| BR (1) | BRPI0817524A2 (enExample) |
| CA (1) | CA2701470A1 (enExample) |
| MX (1) | MX2010003630A (enExample) |
| RU (1) | RU2505311C2 (enExample) |
| WO (1) | WO2009046198A2 (enExample) |
| ZA (1) | ZA201002365B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8168584B2 (en) * | 2005-10-08 | 2012-05-01 | Potentia Pharmaceuticals, Inc. | Methods of treating age-related macular degeneration by compstatin and analogs thereof |
| US20110092446A1 (en) * | 2007-07-20 | 2011-04-21 | Cedric Francois | Compositions and methods for treatment of trauma |
| EP2278987A4 (en) * | 2008-03-28 | 2012-08-22 | Apellis Ag | MODULATION AND REPLY / IMPROVEMENT OF THE COMPLEMENTARY SYSTEM IN THE TREATMENT OF TRAUMATISM |
| TWI492769B (zh) | 2009-09-23 | 2015-07-21 | Alcon Res Ltd | 可注射的水性眼用組成物及其使用之方法 |
| US9421240B2 (en) | 2010-06-22 | 2016-08-23 | Apellis Pharmaceuticals, Inc. | Compstatin analogs for treatment of neuropathic pain |
| US9107822B2 (en) | 2010-09-03 | 2015-08-18 | Santen Sas | Water-in oil type emulsion for treating a disease of the eye |
| EP2425814B1 (en) | 2010-09-03 | 2013-06-19 | Novagali Pharma S.A. | A water-in-oil type emulsion for treating a disease of the eye |
| NZ607103A (en) | 2010-09-03 | 2015-09-25 | Santen Sas | A water-in-oil type emulsion for treating a disease of the eye |
| US10125171B2 (en) | 2011-05-11 | 2018-11-13 | Apellis Pharmaceuticals, Inc. | Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof |
| BR112013033272A2 (pt) | 2011-06-22 | 2020-11-10 | Apellis Pharmaceuticals, Inc. | composição farmaceutica compreendendo um inibidor do complemento e um agente anti-th17, e usos dos mesmos |
| WO2014028861A1 (en) * | 2012-08-17 | 2014-02-20 | Apellis Pharmaceuticals, Inc. | Detection of high risk drusen |
| CN110882376B (zh) | 2012-11-15 | 2023-10-20 | 阿佩利斯制药公司 | 细胞反应性的、长效的或靶向的坎普他汀类似物及相关组合物和方法 |
| WO2014152391A1 (en) | 2013-03-15 | 2014-09-25 | Apellis Pharmaceuticals, Inc. | Cell-penetrating compstatin analogs and uses thereof |
| US9940683B2 (en) | 2013-07-31 | 2018-04-10 | Elwha Llc | Managing a risk of a liability that is incurred if a subject treated for a condition is retreated within a specified time period |
| US20150039337A1 (en) * | 2013-07-31 | 2015-02-05 | Elwha Llc | Managing a risk of a liability that is incurred if one or more subjects each treated for a respective condition are retreated within a respective specified time period |
| EP2918262B1 (en) | 2014-03-10 | 2023-08-09 | PLS-Design GmbH | Induction of antigen-specific tolerance by peripheral phagocytosis |
| JP6432954B2 (ja) | 2014-06-12 | 2018-12-05 | ラ ファーマシューティカルズ インコーポレイテッドＲａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 補体活性の変調 |
| CA2970502A1 (en) * | 2014-12-12 | 2016-06-16 | The Schepens Eye Research Institute, Inc. | Gdnf induction for the treatment of retinal disorders |
| SI3250230T1 (sl) | 2015-01-28 | 2022-01-31 | Ra Pharmaceuticals, Inc. | Modulatorji aktivnosti komplementa |
| EP3095440B1 (en) | 2015-05-19 | 2020-01-15 | PLS-Design GmbH | Antigen-specific immunotherapy using tolerizing liposomes |
| HK1259307A1 (zh) | 2015-10-07 | 2019-11-29 | 阿佩利斯制药有限公司 | 给药方案 |
| AU2016370210A1 (en) * | 2015-12-16 | 2018-06-21 | Ra Pharmaceuticals, Inc. | Modulators of complement activity |
| JP7301741B2 (ja) | 2016-12-07 | 2023-07-03 | ラ ファーマシューティカルズ インコーポレイテッド | 補体活性のモジュレータ |
| RU2661621C2 (ru) * | 2016-12-19 | 2018-07-17 | Александр Николаевич Епихин | Способ пролонгации и усиления терапевтического эффекта действия ингибиторов ангиогенеза при лечении неоваскулярных форм макулярных дегенераций |
| KR20240135047A (ko) | 2017-04-07 | 2024-09-10 | 아펠리스 파마슈티컬스 인코포레이티드 | 투여 요법 및 관련 조성물 및 방법 |
| AU2018386304B2 (en) * | 2017-12-15 | 2023-12-07 | Apellis Pharmaceuticals, Inc. | Dosing regimens and related compositions and methods |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6660843B1 (en) * | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| US7488590B2 (en) * | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
| ES2373649T3 (es) * | 2002-09-20 | 2012-02-07 | The Trustees Of The University Of Pennsylvania | Análogos de compstatina con actividad mejorada. |
| US8168584B2 (en) * | 2005-10-08 | 2012-05-01 | Potentia Pharmaceuticals, Inc. | Methods of treating age-related macular degeneration by compstatin and analogs thereof |
| AU2006302212B2 (en) * | 2005-10-08 | 2012-12-20 | Apellis Pharmaceuticals, Inc. | Compstatin and analogs thereof for eye disorders |
| PT1960422E (pt) * | 2005-11-28 | 2012-08-16 | Univ Pennsylvania | Análogos de compstatina potentes |
| JP2009521506A (ja) * | 2005-12-22 | 2009-06-04 | アルコン リサーチ， リミテッド | 補体因子ｈの危険である改変体をもつ患者における年齢による斑状変性の予防および処置のためのｃ３コンバターゼインヒビター |
| US20070196367A1 (en) * | 2006-02-22 | 2007-08-23 | Valentin Dinu | Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system |
| US8580735B2 (en) * | 2007-02-05 | 2013-11-12 | Apellis Pharmaceuticals, Inc. | Local complement inhibition for treatment of complement-mediated disorders |
-
2008
- 2008-10-02 KR KR1020107008703A patent/KR20100094453A/ko not_active Ceased
- 2008-10-02 US US12/681,392 patent/US20110182877A1/en not_active Abandoned
- 2008-10-02 WO PCT/US2008/078593 patent/WO2009046198A2/en not_active Ceased
- 2008-10-02 BR BRPI0817524A patent/BRPI0817524A2/pt not_active IP Right Cessation
- 2008-10-02 KR KR1020157016589A patent/KR20150080007A/ko not_active Ceased
- 2008-10-02 AU AU2008308657A patent/AU2008308657A1/en not_active Abandoned
- 2008-10-02 RU RU2010113513/15A patent/RU2505311C2/ru not_active IP Right Cessation
- 2008-10-02 CA CA2701470A patent/CA2701470A1/en not_active Abandoned
- 2008-10-02 MX MX2010003630A patent/MX2010003630A/es unknown
- 2008-10-02 CN CN200880115155A patent/CN101854916A/zh active Pending
- 2008-10-02 EP EP08836209.0A patent/EP2207530A4/en not_active Withdrawn
- 2008-10-02 JP JP2010528129A patent/JP2010540654A/ja active Pending
-
2010
- 2010-04-01 ZA ZA2010/02365A patent/ZA201002365B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2505311C2 (ru) | 2014-01-27 |
| CN101854916A (zh) | 2010-10-06 |
| JP2010540654A (ja) | 2010-12-24 |
| ZA201002365B (en) | 2010-12-29 |
| US20110182877A1 (en) | 2011-07-28 |
| RU2010113513A (ru) | 2011-11-10 |
| KR20100094453A (ko) | 2010-08-26 |
| EP2207530A2 (en) | 2010-07-21 |
| CA2701470A1 (en) | 2009-04-09 |
| KR20150080007A (ko) | 2015-07-08 |
| WO2009046198A3 (en) | 2009-07-16 |
| WO2009046198A2 (en) | 2009-04-09 |
| AU2008308657A1 (en) | 2009-04-09 |
| EP2207530A4 (en) | 2013-09-11 |
| MX2010003630A (es) | 2010-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0817524A2 (pt) | liberação prolongada de análogos de compstatina provenientes de géis | |
| BRPI0911269A2 (pt) | análogos de halicondrina b | |
| EP2398483A4 (en) | Oxyntomodulin Analogs | |
| DK2361256T3 (da) | Cyclohexenyl-nukleinsyreanaloger | |
| EP2096917A4 (en) | Cyclopamine ANALOG | |
| DE602009000580D1 (de) | Endoskopsystem | |
| BRPI0922508A2 (pt) | Análogos de nucleosídeo | |
| EP2029597A4 (en) | purine analogs | |
| EP2298608A4 (en) | ELECTRICAL BEAM | |
| BRPI0813647A2 (pt) | Piperazinil oxoalquil tetrahidro-beta-carbolinas e análogos relacionados | |
| BRPI0718548A2 (pt) | Estabilização de vacinas por liofilização | |
| EP2246950A4 (en) | EYELET | |
| FI20085277A0 (fi) | Kohdunsisäinen järjestelmä | |
| EP2312590A4 (en) | Wire harness | |
| DK2260053T3 (da) | Oxytocin-analoger | |
| EP2327960A4 (en) | MICROELECTROMECHANICAL SYSTEM | |
| DE602006009894D1 (de) | Verbesserter Flash-ADC | |
| EP2110789A4 (en) | PAPER MONEY PROCESSOR | |
| BRPI0814876A2 (pt) | Análogos de pirona fosforilados e métodos | |
| EP2321966A4 (en) | BRIGHTNESS EVALUATION | |
| DK2237727T3 (da) | Vævsretraktor | |
| CR10675A (es) | Analogos de 2-fenoxipirimidinona | |
| BRPI0811864A2 (pt) | Derivados de ácido cistéico de peptídeos antivirais | |
| BRPI0811132A2 (pt) | Preparação de catalisadores de paládio-ouro | |
| BRPI0917673A2 (pt) | Combinação de herbicida-protetor compreendendo difluorometanossulfonilanilidas substituidas por dimetoxitriazinila |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |